Back to search

University of British Columbia

Investigating molecular and genetic differences in allergic rhinitis phenotypes

Abstract

dc:description

Allergic rhinitis (AR) is a heterogeneous disorder that is associated with inflammation of the upper airways. The prevalence of AR has increased rapidly in recent years, and currently affects 10 - 40% of the global population. Common examples of symptoms experienced after allergen exposure include nasal congestion, rhinorrhea, sneezing, and nasal itching. Additional symptoms include conjunctivitis and exacerbation of comorbid asthma. AR is characterized by an early phase response (EPR) and, in some individuals, a subsequent late-phase response (LPR). The induction of allergic responses can be studied using controlled allergen challenge facilities (CACF). Multiple CACFs have identified three response phenotypes in AR: early responders, protracted early responders, and dual responders. Molecular and genetic differences between AR phenotypes have not been well investigated. In order to identify molecular differences between phenotypes, we used baseline peripheral blood collected from individuals with AR. Blood samples from discovery and validation cohorts were profiled for biomarker candidates using a custom gene expression assay. Using univariate and multivariate analyses, we were unable to identify and validate a clear discriminatory signal between AR phenotypes. Next, we investigated the relationship between single nucleotide polymorphisms (SNPs) in cholinergic synapse pathway genes and the development of the LPR. We specifically looked at the cholinergic synapse pathway because polymorphisms in these genes have previously been associated with late asthmatic responses. Participants were split into two categories based on late-onset congestion, which is the predominant nasal symptom experienced during the LPR: low congestion (LC) and high congestion (HC). Allele frequencies of 25 SNPs located in cholinergic synapse pathway genes (ADCY3, AKT3, CACNA1S, CHRM3, CHRNB2, GNG4, and KCNQ4), were found to be significantly different between HC and LC subgroups. Additionally, we identified that the minor allele content of the HC subgroup was significantly higher than that of the LC subgroup. The cholinergic system may be a potential therapeutic target for the LPR.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Samra, Simranjit

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/77826

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Samra, Simranjit. Investigating molecular and genetic differences in allergic rhinitis phenotypes. master's thesis, University of British Columbia, 2021. http://hdl.handle.net/2429/77826